McMaster start-up Empirica Therapeutics has been acquired by Philadelphia-based Century Therapeutics, a leader in curative cell therapies for cancer. Now known as Century Therapeutics Canada, the new subsidiary will be based at McMaster Innovation Park.
Researchers at McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.
A networking think tank focused on fostering success in entrepreneurship and innovation has been formed at McMaster University.
McMaster logo
McMaster logo
